London: Scientists have found specific genes associated with a rare liver disease that could provide a valuable tool for therapy, says a study.The large-scale genetic study defines the relationship between primary sclerosing cholangitis and other autoimmune diseases.Researchers have newly associated nine genetic regions with a rare autoimmune disease of the liver known as primary sclerosing cholangitis (PSC). This brings the total number of genetic regions associated with the disease to 16.Approximately 70 percent of people who suffer from PSC also suffer from IBD.The team showed that only half of the newly associated genetic regions were shared with inflammatory bowel disease (IBD).For the first time, this definitively proves that PSC, although genetically related to IBD, is a distinct disease.PSC is a chronic, progressive disease of the bile ducts that channels bile from the liver into the intestines. It can cause inflammation of the bile ducts (cholangitis) and liver scarring that leads to liver cirrhosis and liver failure.There are no effective treatments available.
Depression leads to heart disease and vice versa
Slow pace linked to early death in kidney disease patients